RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:641368

Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency

medium confidenceDisorder

Also known as: AR-HIES due to ZNF341 deficiency · Autosomal recessive HIES due to ZNF341 deficiency · Autosomal recessive hyperimmunoglobulin E syndrome due to zinc finger protein 341 deficiency

Publications

308

74.6th percentile

Trials

0

Interventional, condition-specific

Researchers

75

Distinct authors in sample

Gene link

ZNF341

Definitive

Readiness

4/6

Stages with a signal

Clinical definition (Orphanet)

A rare hyper-IgE syndrome characterized by atopic dermatitis (eczema), chronic mucocutaneous candidiasis, and elevated IgE levels due to ZNF341 deficiency. High plasma levels of IgG and low natural killer (NK) cell numbers are observed. Other major clinical features involve recurrent skin infections with skin abscesses and connective tissue abnormalities. Some patients may have recurrent lung infections.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (2)

HIES3 · autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

4/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedPresent

    Definitive — ZNF341

  2. LiteraturePresent

    308 matched papers (286 in last 10 years) Source

  3. Phenotype characterisedPresent

    30 HPO annotations (e.g. Sterile abscess; Recurrent oral thrush; Recurrent mucocutaneous candidiasis) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialPartial

    None under the specific name; 4 for broader category hyper-IgE syndrome

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (ZNF341).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

30

Associated phenotypes · MONDO:0957426

  • Sterile abscess
  • Recurrent oral thrush
  • Recurrent mucocutaneous candidiasis
  • Abnormality of the dentition
  • Mild intellectual disability

Showing 5 of 30 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

308

308 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

308 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

286 in the last 10 years · medium confidence · 74.6th percentile (publications denominator)

Phrase hits: 12 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

75

Distinct author names in 12 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Abidov A1 paper · 2025

    Division of Immunology, University of Iowa Hospitals and Clinics, Iowa City, IA, United States.

    Papers in Europe PMC
  2. 02
    Aelami MH1 paper · 2026

    Hand Hygiene and Infection Control Research Center Imam Reza Hospital, Mashhad, Iran.

    Papers in Europe PMC
  3. 03
    Ahanchian H1 paper · 2026

    Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

    Papers in Europe PMC
  4. 04
    August A1 paper · 2018

    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. Email: averyaugust@cornell.edu.

    Papers in Europe PMC
  5. 05
    Bayer DK1 paper · 2025

    Stead Family Department of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States.

    Papers in Europe PMC
  6. 06
    Beck LA1 paper · 2022

    Department of Dermatology, University of Rochester Medical Center, New York, USA. Electronic address: lisa_beck@urmc.rochester.edu.

    Papers in Europe PMC
  7. 07
    Boehm M1 paper · 2019

    Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

    Papers in Europe PMC
  8. 08
    Bonnal S1 paper · 2018

    Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona, 08002, Spain.

    Papers in Europe PMC
  9. 09
    Chen G1 paper · 2019

    Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: chengb@nhlbi.nih.gov.

    Papers in Europe PMC
  10. 10
    Chen YH1 paper · 2021

    Translational Gastroenterology Unit, University of Oxford, Oxford, UK.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 4 trials are registered for hyper-IgE syndrome, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

medium confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

4 interventional trials matched hyper-IgE syndrome, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: hyper-IgE syndrome

4

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency" OR "AR-HIES due to ZNF341 deficiency" OR "Autosomal recessive HIES due to ZNF341 deficiency" OR "Autosomal recessive hyperimmunoglobulin E syndrome due to zinc finger protein 341 deficiency" OR "HIES3") OR ("ZNF341" OR "ZNF341 syndrome" OR "ZNF341-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency" OR "AR-HIES due to ZNF341 deficiency" OR "Autosomal recessive HIES due to ZNF341 deficiency" OR "Autosomal recessive hyperimmunoglobulin E syndrome due to zinc finger protein 341 deficiency" OR "HIES3"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"hyper-IgE syndrome"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (308) is high for prevalence class "<1 / 1 000 000" — confidence capped at medium

Ingested 2026-07-27T19:33:58.238Z